Free Trial

OR Royalties Inc. $OR Shares Sold by JPMorgan Chase & Co.

OR Royalties logo with Basic Materials background
Image from MarketBeat Media, LLC.

Key Points

  • JPMorgan Chase & Co. cut its stake in OR Royalties by 45.3% in Q3, selling 93,037 shares and ending the period with 112,139 shares worth $4.495 million (about 0.06% of the company).
  • OR shares trade in a one‑year range of $18.99–$48.06 with a market cap of $7.56B and a P/E of 36.95, and the company announced a quarterly dividend of $0.055 payable Apr 15 (yield ~0.5%, ex‑div Mar 31).
  • OR beat Q results slightly (EPS $0.32 vs. $0.31), reported a 74.3% net margin, and carries an average analyst rating of Moderate Buy with a $38.25 price target.
  • MarketBeat previews the top five stocks to own by May 1st.

JPMorgan Chase & Co. decreased its position in OR Royalties Inc. (NYSE:OR - Free Report) by 45.3% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 112,139 shares of the basic materials company's stock after selling 93,037 shares during the period. JPMorgan Chase & Co. owned about 0.06% of OR Royalties worth $4,495,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Cetera Investment Advisers boosted its position in shares of OR Royalties by 3.5% in the 2nd quarter. Cetera Investment Advisers now owns 13,147 shares of the basic materials company's stock worth $337,000 after buying an additional 440 shares in the last quarter. Vident Advisory LLC raised its position in OR Royalties by 2.0% during the second quarter. Vident Advisory LLC now owns 42,349 shares of the basic materials company's stock worth $1,089,000 after acquiring an additional 820 shares during the last quarter. HighTower Advisors LLC raised its position in OR Royalties by 1.4% during the third quarter. HighTower Advisors LLC now owns 79,518 shares of the basic materials company's stock worth $3,187,000 after acquiring an additional 1,088 shares during the last quarter. Vanguard Personalized Indexing Management LLC lifted its holdings in shares of OR Royalties by 9.6% in the third quarter. Vanguard Personalized Indexing Management LLC now owns 16,471 shares of the basic materials company's stock valued at $660,000 after purchasing an additional 1,446 shares in the last quarter. Finally, Verition Fund Management LLC lifted its holdings in shares of OR Royalties by 0.3% in the third quarter. Verition Fund Management LLC now owns 632,705 shares of the basic materials company's stock valued at $25,359,000 after purchasing an additional 1,949 shares in the last quarter. Hedge funds and other institutional investors own 68.52% of the company's stock.

OR Royalties Stock Performance

Shares of OR opened at $40.27 on Friday. OR Royalties Inc. has a 1 year low of $18.99 and a 1 year high of $48.06. The company's 50 day simple moving average is $41.39 and its 200 day simple moving average is $37.95. The company has a market capitalization of $7.56 billion, a price-to-earnings ratio of 36.95 and a beta of 0.83.

OR Royalties (NYSE:OR - Get Free Report) last released its earnings results on Wednesday, February 18th. The basic materials company reported $0.32 EPS for the quarter, topping the consensus estimate of $0.31 by $0.01. The firm had revenue of $90.47 million during the quarter, compared to analysts' expectations of $90.80 million. OR Royalties had a net margin of 74.30% and a return on equity of 12.73%. Equities analysts expect that OR Royalties Inc. will post 0.62 EPS for the current fiscal year.

OR Royalties Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 15th. Investors of record on Tuesday, March 31st will be paid a $0.055 dividend. This represents a $0.22 annualized dividend and a yield of 0.5%. The ex-dividend date is Tuesday, March 31st. OR Royalties's dividend payout ratio is presently 20.18%.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on OR shares. Canadian Imperial Bank of Commerce restated an "outperform" rating on shares of OR Royalties in a research report on Wednesday, February 4th. Scotiabank raised their price target on OR Royalties from $41.00 to $51.00 and gave the stock a "sector perform" rating in a research report on Monday, January 26th. Weiss Ratings reissued a "buy (b)" rating on shares of OR Royalties in a report on Monday, December 29th. Zacks Research downgraded OR Royalties from a "strong-buy" rating to a "hold" rating in a research report on Tuesday. Finally, Jefferies Financial Group reaffirmed a "hold" rating and set a $38.00 price objective on shares of OR Royalties in a research note on Sunday, December 7th. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and four have given a Hold rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $38.25.

Check Out Our Latest Report on OR

About OR Royalties

(Free Report)

OR Royalties PLC NYSE: OR is a closed-ended investment company that specializes in acquiring and managing royalty interests in life science and pharmaceutical products. The company provides capital to biotechnology, specialty pharmaceutical and medical device companies in exchange for a share of future sales revenues. By focusing on royalties secured against marketed products, OR Royalties aims to deliver income and growth potential while minimizing the development and commercialization risks typically associated with direct equity stakes.

The company's core activities include sourcing royalty transactions, structuring bespoke financing solutions and actively monitoring a diversified portfolio of assets.

Featured Articles

Want to see what other hedge funds are holding OR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for OR Royalties Inc. (NYSE:OR - Free Report).

Institutional Ownership by Quarter for OR Royalties (NYSE:OR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in OR Royalties Right Now?

Before you consider OR Royalties, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and OR Royalties wasn't on the list.

While OR Royalties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines